应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SLRN Acelyrin, Inc.
交易中 11-14 15:17:38 EST
5.16
-0.82
-13.71%
最高
6.19
最低
5.02
成交量
94.08万
今开
6.10
昨收
5.98
日振幅
19.57%
总市值
5.15亿
流通市值
3.32亿
总股本
9,981万
成交额
519.25万
换手率
1.46%
流通股本
6,430万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Acelyrin, Inc.盘中异动 大幅下跌5.35%报5.66美元
市场透视 · 11-14 22:37
Acelyrin, Inc.盘中异动 大幅下跌5.35%报5.66美元
美国研究综述-思科、Freshpet、Nvidia
路透中文 · 11-14 20:06
美国研究综述-思科、Freshpet、Nvidia
ACELYRIN Inc 预计每股亏损80美分 - 财报前瞻
Reuters · 11-12 11:52
ACELYRIN Inc 预计每股亏损80美分 - 财报前瞻
Acelyrin, Inc.盘中异动 股价大跌5.08%
市场透视 · 10-31
Acelyrin, Inc.盘中异动 股价大跌5.08%
Acelyrin, Inc.盘中异动 股价大涨5.43%
市场透视 · 10-18
Acelyrin, Inc.盘中异动 股价大涨5.43%
Acelyrin, Inc.盘中异动 股价大涨5.24%报6.02美元
市场透视 · 10-16
Acelyrin, Inc.盘中异动 股价大涨5.24%报6.02美元
Acelyrin, Inc.盘中异动 早盘股价大跌5.12%
市场透视 · 10-07
Acelyrin, Inc.盘中异动 早盘股价大跌5.12%
Acelyrin, Inc.盘中异动 股价大跌5.11%
市场透视 · 10-02
Acelyrin, Inc.盘中异动 股价大跌5.11%
Acelyrin, Inc.盘中异动 大幅拉升8.70%
市场透视 · 09-19
Acelyrin, Inc.盘中异动 大幅拉升8.70%
Acelyrin, Inc.盘中异动 急速拉升5.38%
自选股智能写手 · 08-20
Acelyrin, Inc.盘中异动 急速拉升5.38%
Acelyrin, Inc.盘中异动 临近收盘急速拉升5.08%报4.34美元
自选股智能写手 · 08-20
Acelyrin, Inc.盘中异动 临近收盘急速拉升5.08%报4.34美元
Acelyrin, Inc.2024财年第二财季实现净利润-85.67百万美元,同比减少228.99%
自选股智能写手 · 08-19
Acelyrin, Inc.2024财年第二财季实现净利润-85.67百万美元,同比减少228.99%
Acelyrin, Inc.盘中异动 股价大涨5.53%
自选股智能写手 · 08-17
Acelyrin, Inc.盘中异动 股价大涨5.53%
Acelyrin, Inc.盘中异动 快速拉升6.16%报4.31美元
自选股智能写手 · 08-15
Acelyrin, Inc.盘中异动 快速拉升6.16%报4.31美元
BUZZ--美国股票走势-Allstate、Progressive、Serve Robotics
Reuters · 08-15
BUZZ--美国股票走势-Allstate、Progressive、Serve Robotics
BUZZ--美国股票走势-Acelyrin、卡地纳健康公司、夏威夷控股公司
Reuters · 08-14
BUZZ--美国股票走势-Acelyrin、卡地纳健康公司、夏威夷控股公司
Acelyrin, Inc.股价重挫18.49% 市值跌7160.36万美元
自选股智能写手 · 08-14
Acelyrin, Inc.股价重挫18.49% 市值跌7160.36万美元
BUZZ-Acelyrin 在 H.C. Wainwright 下调评级至 "中性 "后下跌
Reuters · 08-14
BUZZ-Acelyrin 在 H.C. Wainwright 下调评级至 "中性 "后下跌
美国研究综述-Agenus、Guardant Health、Zoetis
Reuters · 08-14
美国研究综述-Agenus、Guardant Health、Zoetis
BUZZ-Acelyrin因拟裁员、皮肤病药物后期数据良好而攀升
Reuters · 08-14
BUZZ-Acelyrin因拟裁员、皮肤病药物后期数据良好而攀升
暂无数据
公司概况
公司名称:
Acelyrin, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Acelyrin, Inc于2020年7月27日在美国特拉华州注册成立。Acelyrin, Inc是一家处于后期阶段的生物制药公司,专注于识别、收购和加速变革性药物的开发和商业化。自成立以来,公司投入了几乎所有的资源来组织公司、招聘人员、业务规划、获取和开发其候选产品、进行研发、支持其产品开发工作的制造活动、建立和保护其知识产权组合、筹集资金以及为这些活动提供一般和行政支持。
发行价格:
--
{"stockData":{"symbol":"SLRN","market":"US","secType":"STK","nameCN":"Acelyrin, Inc.","latestPrice":5.16,"timestamp":1731615452325,"preClose":5.98,"halted":0,"volume":940773,"delay":0,"floatShares":64304337,"shares":99808262,"eps":-3.058182,"marketStatus":"交易中","marketStatusCode":2,"change":-0.82,"latestTime":"11-14 15:17:38 EST","open":6.1,"high":6.19,"low":5.02,"amount":5192527.897071,"amplitude":0.195652,"askPrice":5.16,"askSize":1079,"bidPrice":5.15,"bidSize":472,"shortable":0,"etf":0,"ttmEps":-3.058182,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1731618000000},"adr":0,"listingDate":1683259200000,"adjPreClose":5.98,"postHourTrading":{"tag":"盘后","latestPrice":6.23,"preClose":5.98,"latestTime":"17:43 EST","volume":19674,"amount":117913.84,"timestamp":1731537790695},"volumeRatio":3.037313,"impliedVol":1.4505,"impliedVolPercentile":0.5198},"requestUrl":"/m/hq/s/SLRN/tweets","defaultTab":"tweets","newsList":[{"id":"2483804293","title":"Acelyrin, Inc.盘中异动 大幅下跌5.35%报5.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483804293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483804293?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:37","pubTimestamp":1731595027,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时37分,Acelyrin, Inc.股票出现波动,股价快速下跌5.35%。截至发稿,该股报5.66美元/股,成交量4.2343万股,换手率0.04%,振幅7.53%。Acelyrin, Inc.股票所在的生物技术行业中,整体跌幅为0.20%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com涨幅较大,Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.、Adial Pharmaceuticals, Inc较为活跃,换手率分别为1640.97%、22.97%、15.89%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Pds Biotechnology Corporation,振幅分别为75.00%、38.46%、26.13%。Acelyrin, Inc.公司简介:Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223707971a68fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223707971a68fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLRN"],"gpt_icon":0},{"id":"2483050876","title":"美国研究综述-思科、Freshpet、Nvidia","url":"https://stock-news.laohu8.com/highlight/detail?id=2483050876","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483050876?lang=zh_cn&edition=full","pubTime":"2024-11-14 20:06","pubTimestamp":1731585982,"startTime":"0","endTime":"0","summary":"美国研究综述-思科、Freshpet、Nvidia路透11月14日 - 华尔街证券分析师周四调整了对思科、Freshpet 和 Nvidia 等几家美国上市公司的评级和目标价。要闻 * 思科CSCO.O:杰富瑞将目标价从53美元上调至66美元 * Freshpet Inc FRPT.O:奥本海默将目标价从155美元上调至180美元 * ICU Medical Inc ICUI.O:Raymond James将目标价从190美元上调至205美元 * Kronos Bio Inc KRON.O:TD Cowen将目标价从买入下调至持有 * Nvidia Corp NVDA.O:奥本海默将目标价从 150 美元上调至 175 美元 以下是路透周四报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4T3ML18A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683348.USD","AROC","SLRN","CPT","SG9999002232.USD","CAKE","CNNE","CRVS","APEI","BRBR","FDMT","BPMC","DOX","EE","ACRV","BWXT","CSCO","CTRA","CHX","CPAY","IE00BFXG1179.USD","CAVA","LU0234572021.USD","CHGG","CBSH","LU0868494708.USD","AMGN","SPRY","AIT","APD","ADAP","BK4209","LU1244550494.USD","AESI","BKR","LU2106854487.HKD","ALSN","AXTA","ALLO","LU1244550577.SGD","LU0300736492.USD","BIIB","IE00BZ1G4Q59.USD","BTMD","ALMS","AVB","BK4550","COGT","CPB","AZTA"],"gpt_icon":0},{"id":"2482123167","title":"ACELYRIN Inc 预计每股亏损80美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482123167","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482123167?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:52","pubTimestamp":1731383549,"startTime":"0","endTime":"0","summary":" * ACELYRIN公司 将于11月13日公布截至2024年9月30日的财报,预计季度营收将保持不变。* * LSEG分析师对ACELYRIN公司的平均预期是每股亏损80美分。* 华尔街对 ACELYRIN 公司 12 个月目标价的中位数为 9.00 美元,高于其上次收盘价 6.06 美元。11月12日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"ACELYRIN Inc 预计每股亏损80美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLRN"],"gpt_icon":0},{"id":"2479033011","title":"Acelyrin, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479033011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479033011?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:04","pubTimestamp":1730383463,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时04分,Acelyrin, Inc.股票出现波动,股价急速下跌5.08%。截至发稿,该股报5.60美元/股,成交量4.2185万股,换手率0.04%,振幅3.81%。Acelyrin, Inc.股票所在的生物技术行业中,整体跌幅为2.55%。Acelyrin, Inc.公司简介:Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122042398e3fbc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122042398e3fbc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLRN"],"gpt_icon":0},{"id":"2476736438","title":"Acelyrin, Inc.盘中异动 股价大涨5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476736438","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476736438?lang=zh_cn&edition=full","pubTime":"2024-10-18 03:24","pubTimestamp":1729193049,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日03时24分,Acelyrin, Inc.股票出现异动,股价急速拉升5.43%。截至发稿,该股报6.41美元/股,成交量47.2694万股,换手率0.47%,振幅7.89%。Acelyrin, Inc.股票所在的生物技术行业中,整体涨幅为0.08%。其相关个股中,Molecular Templates, Inc.、Notable Labs, Ltd.、Engene Holdings Inc C/Wts 31/10/2028 Cl A涨幅较大,Molecular Templates, Inc.、Notable Labs, Ltd.、180 Life Sciences Corp.较为活跃,换手率分别为3162.79%、1354.52%、294.33%,振幅较大的相关个股有Molecular Templates, Inc.、Notable Labs, Ltd.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ,振幅分别为259.74%、152.93%、147.48%。Acelyrin, Inc.公司简介:Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101803240998e3d10c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101803240998e3d10c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRN","BK4139"],"gpt_icon":0},{"id":"2475992250","title":"Acelyrin, Inc.盘中异动 股价大涨5.24%报6.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475992250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475992250?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:32","pubTimestamp":1729085520,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日21时32分,Acelyrin, Inc.股票出现异动,股价大幅拉升5.24%。截至发稿,该股报6.02美元/股,成交量1.9828万股,换手率0.02%,振幅1.92%。Acelyrin, Inc.股票所在的生物技术行业中,整体跌幅为0.34%。Acelyrin, Inc.公司简介:Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016213200a1e11e9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016213200a1e11e9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRN","BK4139"],"gpt_icon":0},{"id":"2473107604","title":"Acelyrin, Inc.盘中异动 早盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473107604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473107604?lang=zh_cn&edition=full","pubTime":"2024-10-07 23:13","pubTimestamp":1728314024,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日23时13分,Acelyrin, Inc.股票出现波动,股价急速跳水5.12%。截至发稿,该股报4.73美元/股,成交量4.9256万股,换手率0.05%,振幅4.52%。Acelyrin, Inc.股票所在的生物技术行业中,整体跌幅为0.18%。Acelyrin, Inc.公司简介:Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100723134598e3ae35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100723134598e3ae35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLRN"],"gpt_icon":0},{"id":"2472529078","title":"Acelyrin, Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472529078","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472529078?lang=zh_cn&edition=full","pubTime":"2024-10-02 22:07","pubTimestamp":1727878050,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日22时07分,Acelyrin, Inc.股票出现异动,股价快速下挫5.11%。截至发稿,该股报4.83美元/股,成交量3.2829万股,换手率0.03%,振幅4.52%。Acelyrin, Inc.股票所在的生物技术行业中,整体跌幅为1.42%。其相关个股中,Tc Biopharm Plc C/Wts 10/02/2028 、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Chromocell Therapeutics Corporation涨幅较大,Aditxt, Inc.、Tc Biopharm Plc、Windtree Therapeutics, Inc.较为活跃,换手率分别为522.67%、27.52%、23.99%,振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Aditxt, Inc.,振幅分别为145.55%、46.85%、40.28%。Acelyrin, Inc.公司简介:Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410022207319719df6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410022207319719df6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLRN"],"gpt_icon":0},{"id":"2468577021","title":"Acelyrin, Inc.盘中异动 大幅拉升8.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468577021","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468577021?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:31","pubTimestamp":1726752671,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时31分,Acelyrin, Inc.股票出现波动,股价大幅拉升8.70%。截至发稿,该股报5.00美元/股,成交量6.1658万股,换手率0.06%,振幅3.04%。Acelyrin, Inc.股票所在的生物技术行业中,整体涨幅为0.87%。其相关个股中,Exicure, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Humacyte Inc C/Wts 27/08/2026 涨幅较大,Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Psyence Biomedical Ltd.较为活跃,换手率分别为1021.42%、333.61%、70.43%,振幅较大的相关个股有Exicure, Inc.、Autolus Therapeutics Plc、Renovaro Inc.,振幅分别为18.34%、11.37%、9.65%。Acelyrin, Inc.公司简介:Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213111956fa28d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213111956fa28d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRN","BK4139"],"gpt_icon":0},{"id":"2460004162","title":"Acelyrin, Inc.盘中异动 急速拉升5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460004162","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460004162?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:36","pubTimestamp":1724160971,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日21时36分,Acelyrin, Inc.股票出现异动,股价大幅拉升5.38%。截至发稿,该股报4.61美元/股,成交量9.0943万股,换手率0.09%,振幅2.52%。Acelyrin, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。其相关个股中,Inmed Pharmaceuticals Inc.、泰坦制药、Apollomics Inc C/Wts 01/04/2028 涨幅较大,Inmed Pharmaceuticals Inc.、泰坦制药、Alzamend Neuro, Inc.较为活跃,换手率分别为1825.84%、335.65%、192.00%,振幅较大的相关个股有Inmed Pharmaceuticals Inc.、Biomotion Sciences C/Wts Exp 15/08/2029 、泰坦制药,振幅分别为103.31%、78.89%、28.68%。Acelyrin, Inc.公司简介:Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820213611ab5ea326&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820213611ab5ea326&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRN","BK4139"],"gpt_icon":0},{"id":"2460696300","title":"Acelyrin, Inc.盘中异动 临近收盘急速拉升5.08%报4.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460696300","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460696300?lang=zh_cn&edition=full","pubTime":"2024-08-20 03:57","pubTimestamp":1724097431,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日03时57分,Acelyrin, Inc.股票出现波动,股价快速上涨5.08%。截至发稿,该股报4.34美元/股,成交量67.065万股,换手率0.67%,振幅9.32%。Acelyrin, Inc.股票所在的生物技术行业中,整体涨幅为1.02%。其相关个股中,Nucana Plc、Alzamend Neuro, Inc.、Virax Biolabs Group Limited涨幅较大,Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为9569.27%、3952.53%、1351.84%,振幅较大的相关个股有Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Nucana Plc,振幅分别为457.87%、220.18%、211.14%。Acelyrin, Inc.公司简介:Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082003571197199323&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082003571197199323&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRN","BK4139"],"gpt_icon":0},{"id":"2460710303","title":"Acelyrin, Inc.2024财年第二财季实现净利润-85.67百万美元,同比减少228.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460710303","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460710303?lang=zh_cn&edition=full","pubTime":"2024-08-19 00:05","pubTimestamp":1723997102,"startTime":"0","endTime":"0","summary":"8月19日,Acelyrin, Inc.公布财报,公告显示公司2024财年第二财季净利润为-85.67百万美元,同比减少228.99%;其中营业收入为0.00美元,每股基本收益为-0.86美元。从资产负债表来看,Acelyrin, Inc.总负债83.52百万美元,其中短期债务0.00美元,资产负债比为0.08,流动比率为0.08。机构评级:截至2024年8月19日,当前有4家机构对Acelyrin, Inc.目标价做出预测,其中目标均价为12.75美元,其中最低目标价为6.00美元,最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900051195a38707&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900051195a38707&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRN"],"gpt_icon":0},{"id":"2460322924","title":"Acelyrin, Inc.盘中异动 股价大涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460322924","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460322924?lang=zh_cn&edition=full","pubTime":"2024-08-17 03:56","pubTimestamp":1723838174,"startTime":"0","endTime":"0","summary":"北京时间2024年08月17日03时56分,Acelyrin, Inc.股票出现波动,股价大幅拉升5.53%。截至发稿,该股报4.20美元/股,成交量203.168万股,换手率2.04%,振幅5.53%。Acelyrin, Inc.股票所在的生物技术行业中,整体跌幅为0.29%。其相关个股中,Cingulate Inc C/Wts 10/12/2026 、Cingulate Inc.、Geovax Labs, Inc.涨幅较大,Cingulate Inc.、Seelos Therapeutics, Inc.、Geovax Labs, Inc.较为活跃,换手率分别为11243.15%、2239.04%、2002.57%,振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Cingulate Inc.、Geovax Labs, Inc.,振幅分别为788.36%、252.50%、144.78%。Acelyrin, Inc.公司简介:Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081703561497198fff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081703561497198fff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLRN"],"gpt_icon":0},{"id":"2459420450","title":"Acelyrin, Inc.盘中异动 快速拉升6.16%报4.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459420450","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459420450?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:32","pubTimestamp":1723728736,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时32分,Acelyrin, Inc.股票出现波动,股价大幅上涨6.16%。截至发稿,该股报4.31美元/股,成交量6.9794万股,换手率0.07%,振幅4.95%。Acelyrin, Inc.股票所在的生物技术行业中,整体涨幅为0.60%。其相关个股中,Cingulate Inc.、Nutriband Inc C/Wts 、Scisparc Ltd.涨幅较大,Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃,换手率分别为2428.43%、1473.25%、337.91%,振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Cingulate Inc C/Wts 10/12/2026 、Cingulate Inc.,振幅分别为52.18%、32.31%、28.18%。Acelyrin, Inc.公司简介:Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213216a1d47086&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213216a1d47086&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRN","BK4139"],"gpt_icon":0},{"id":"2459102852","title":"BUZZ--美国股票走势-Allstate、Progressive、Serve Robotics","url":"https://stock-news.laohu8.com/highlight/detail?id=2459102852","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459102852?lang=zh_cn&edition=full","pubTime":"2024-08-15 00:21","pubTimestamp":1723652483,"startTime":"0","endTime":"0","summary":" * 个股异动的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 8月14日 - 华尔街主要股指周三涨跌不一,Alphabet下滑,通胀缓和的迹象使人们继续押注美国联邦储备理事会将于下月开始其宽松政策周期,尽管降息幅度较小。美东时间11:33,标普500指数 上涨0.30%,报5450.85点;纳斯达克综合指数 下跌0.18%,报17157.509点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","HL","K","CDE","NQmain","DE","LU1989763690.USD","LHX","PGR","MNQmain","HA","ALL","DJX","AGCO",".SPX",".IXIC","DDM","LU1880398471.USD","QID","QLD",".DJI","EAT","SCHW","DOG","SQQQ","SDOW","LU1917777945.USD","RILY","HLT","SERV","PSQ","DXD","SPHR","LUV","VRCA","LU0052756011.USD","LU0154245673.USD","CAH","INTU","LU0158827781.USD","UDOW","SLRN","XP","CNH","LU1267930490.SGD","BLUE","EU","TQQQ"],"gpt_icon":1},{"id":"2459177749","title":"BUZZ--美国股票走势-Acelyrin、卡地纳健康公司、夏威夷控股公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2459177749","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459177749?lang=zh_cn&edition=full","pubTime":"2024-08-14 22:08","pubTimestamp":1723644500,"startTime":"0","endTime":"0","summary":" * 个股异动的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 8月14日 - 数据显示通胀如预期般放缓,巩固了美国联邦储备理事会下月启动宽松政策周期的赌注,华尔街周三开盘表现平淡。美东时间9:46,道指电子盘 上涨0.10%,报39,930点。标普500指数小型股 下跌0.03%,报5,457.5点;纳斯达克100指数小型股 下跌0.15%,报19,076点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0096364046.USD","LU1880398471.USD","IE00B1XK9C88.USD","LU0130103400.USD","LU1989763690.USD","SGXZ23171101.USD","VRCA","LU0511384066.AUD","LU1988902786.USD","BK4504","BK4588","LU1064131342.USD","BK4566","CNH","DE","CAH","BK4550","AGCO","LU0096362180.USD","HA","LU0310799852.SGD","BK4503","LU0980610538.SGD","SLRN","BK4500","LU1989763427.SGD","LU1718418525.SGD","SPHR","BK4514","LU1267930813.SGD","LU0471298777.SGD","LU1880398554.USD","LU0130102774.USD","LU0889566641.SGD","LU1720051017.SGD","LU1201861165.SGD","BK4212","LU0149725797.USD","LU0106261372.USD","IE00BK4W5M84.HKD","IE00BWXC8680.SGD","LU0097036916.USD","LUV","K","IE0004086264.USD","LU0154236417.USD","IE00BK4W5L77.USD","BUZZ","LU1201861249.SGD"],"gpt_icon":1},{"id":"2459174382","title":"Acelyrin, Inc.股价重挫18.49% 市值跌7160.36万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459174382","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459174382?lang=zh_cn&edition=full","pubTime":"2024-08-14 21:31","pubTimestamp":1723642285,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日21时31分,Acelyrin, Inc.股票出现波动,股价快速下跌18.49%。截至发稿,该股报3.88美元/股,成交量21.8454万股,换手率0.22%,振幅9.24%。Acelyrin, Inc.股票所在的生物技术行业中,整体跌幅为0.28%。其相关个股中,Conduit Pharmaceuticals Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Genprex, Inc.涨幅较大,Conduit Pharmaceuticals Inc.、Viracta Therapeutics, Inc.、Genprex, Inc.较为活跃,换手率分别为49.00%、42.74%、22.97%,振幅较大的相关个股有Genprex, Inc.、Acelyrin, Inc.、Cadrenal Therapeutics, Inc.,振幅分别为12.91%、9.24%、8.88%。Acelyrin, Inc.公司简介:Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814213125959884ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814213125959884ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRN","BK4139"],"gpt_icon":0},{"id":"2459408176","title":"BUZZ-Acelyrin 在 H.C. Wainwright 下调评级至 \"中性 \"后下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2459408176","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459408176?lang=zh_cn&edition=full","pubTime":"2024-08-14 21:00","pubTimestamp":1723640407,"startTime":"0","endTime":"0","summary":"** 添加药物 izokibep 在治疗皮肤炎症性疾病化脓性扁桃体炎的后期试验中达到了主要目标;公司将暂停对该疗法的进一步投资** H.C. Wainwright 券商将该公司的股票评级下调至 \"中性\",并将目标价从 18 美元下调至 6 美元,称该公司股票在目前的发展阶段对 lonigutamab 机会的定价 \"公平\"。** 取消对 izokibep 的销售预期,认为该药的积极结果不具竞争力** 杰富瑞和派珀桑德勒分别将该公司的目标股价下调至 12 美元和 20 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLRN","BUZZ"],"gpt_icon":0},{"id":"2459110671","title":"美国研究综述-Agenus、Guardant Health、Zoetis","url":"https://stock-news.laohu8.com/highlight/detail?id=2459110671","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459110671?lang=zh_cn&edition=full","pubTime":"2024-08-14 14:49","pubTimestamp":1723618162,"startTime":"0","endTime":"0","summary":" 路透8月14日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价,其中包括 Agenus、Guardant Health 和 Zoetis。要闻 * Agenus Inc :B. Riley将目标价从42美元下调至18美元 * Clorox :杰富瑞将目标价从 148 美元上调至 151 美元 * Guardant Health Inc :Raymond James将目标价从28美元上调至36美元 * 星巴克 :Stifel将其评级从 \"持有 \"上调至 \"买入\";将目标价从80美元上调至110美元 * Zoetis Inc :Piper Sandler将目标价从195美元上调至210美元 以下是路透周三报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FEMY","AIZ","BALL","AEP","BOLD","DUK","FE","CNP","EIX","LU","EMR","ALUR","CTNM","AWK","ED","AGEN","FENC","FTHM","LU0942090050.USD","LU2506952337.HKD","LU0205193047.USD","LU1363072403.SGD","EXC","CMS","ADVM","CLX","IDXX","ATKR","HD","CPK","LU2211815571.USD","AMCX","ES","ETR","ANNX","MO","LU0149725797.USD","BHF","GH","IBTA","HEI","LU2506952410.USD","SKY","SLRN","D","BKH","WTRG"],"gpt_icon":1},{"id":"2459554321","title":"BUZZ-Acelyrin因拟裁员、皮肤病药物后期数据良好而攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2459554321","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459554321?lang=zh_cn&edition=full","pubTime":"2024-08-14 05:47","pubTimestamp":1723585648,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 8月13日 - ** 药物开发商 Acelyrin 的股票在盘后交易中上涨 ~5% 至 5 美元** 公司表示,作为重组计划的一部分, (link),将裁员约 40 人,即约 33** 公司预计重组将延长现金流至 2027 年中期** 药物 izokibep 在治疗化脓性扁平苔癣(一种炎症性皮肤病)的后期试验中达到了主要目标 - SLRN** 截至上次收盘,股价累计下跌 36","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLRN","BK4139","BUZZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.acelyrin.com","stockEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":0.0736},{"period":"3month","weight":0.5025},{"period":"6month","weight":0.3622},{"period":"1year","weight":-0.3281},{"period":"ytd","weight":-0.1984}],"compareEarnings":[{"period":"1week","weight":0.0104},{"period":"1month","weight":0.022},{"period":"3month","weight":0.0798},{"period":"6month","weight":0.1279},{"period":"1year","weight":0.3308},{"period":"ytd","weight":0.2564}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Acelyrin, Inc于2020年7月27日在美国特拉华州注册成立。Acelyrin, Inc是一家处于后期阶段的生物制药公司,专注于识别、收购和加速变革性药物的开发和商业化。自成立以来,公司投入了几乎所有的资源来组织公司、招聘人员、业务规划、获取和开发其候选产品、进行研发、支持其产品开发工作的制造活动、建立和保护其知识产权组合、筹集资金以及为这些活动提供一般和行政支持。","exchange":"NASDAQ","name":"Acelyrin, Inc.","nameEN":"Acelyrin, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Acelyrin, Inc.(SLRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Acelyrin, Inc.(SLRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Acelyrin, Inc.,SLRN,Acelyrin, Inc.股票,Acelyrin, Inc.股票老虎,Acelyrin, Inc.股票老虎国际,Acelyrin, Inc.行情,Acelyrin, Inc.股票行情,Acelyrin, Inc.股价,Acelyrin, Inc.股市,Acelyrin, Inc.股票价格,Acelyrin, Inc.股票交易,Acelyrin, Inc.股票购买,Acelyrin, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Acelyrin, Inc.(SLRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Acelyrin, Inc.(SLRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}